GLP1R and Alzheimer disease: The findings highlight key trends in the efficacy of antidiabetic drugs for AD and AD-related dementia, particularly the promising role of GLP1 agonists or metformin, and suggest potential avenues for repurposing these drugs as treatments for AD.